Respiratory and mental health effects of wildfires: an ecological study in Galician municipalities (north-west Spain) by Caamano-Isorna, Francisco et al.
RESEARCH Open Access
Respiratory and mental health effects of wildfires:
an ecological study in Galician municipalities
(north-west Spain)
Francisco Caamano-Isorna
1*, Adolfo Figueiras
1, Isabel Sastre
1,2, Agustín Montes-Martínez
1, Margarita Taracido,
1 and
María Piñeiro-Lamas
1
Abstract
Background: During the summer of 2006, a wave of wildfires struck Galicia (north-west Spain), giving rise to a
disaster situation in which a great deal of the territory was destroyed. Unlike other occasions, the wildfires in this
case also threatened farms, houses and even human lives, with the result that the perception of disaster and
helplessness was the most acute experienced in recent years. This study sought to analyse the respiratory and
mental health effects of the August-2006 fires, using consumption of anxiolytics-hypnotics and drugs for
obstructive airway diseases as indicators.
Methods: We conducted an analytical, ecological geographical- and temporal-cluster study, using municipality-
month as the study unit. The independent variable was exposure to wildfires in August 2006, with municipalities
thus being classified into the following three categories: no exposure; medium exposure; and high exposure.
Dependent variables were: (1) anxiolytics-hypnotics; and (2) drugs for obstructive airway diseases consumption.
These variables were calculated for the two 12-month periods before and after August 2006. Additive models for
time series were used for statistical analysis purposes.
Results: The results revealed a higher consumption of drugs for obstructive airway diseases among pensioners
during the months following the wildfires, in municipalities affected versus those unaffected by fire. In terms of
consumption of anxiolytics-hypnotics, the results showed a significant increase among men among men overall
-pensioners and non-pensioners- in fire-affected municipalities.
Conclusions: Our study indicates that wildfires have a significant effect on population health. The coherence of
these results suggests that drug utilisation research is a useful tool for studying morbidity associated with
environmental incidents.
Background
Traumatic events, such as wildfires, can generate psy-
chiatric pathology among the exposed section of the
population, i.e., those who are most vulnerable owing to
their specific temperamental and neurobiological charac-
teristics, which would act as vulnerability factors ("vul-
nerability/stress model”). Often, subjects exposed to a
traumatic event develop adaptive reactions, which may
turn into an acute stress disorder, a common forerunner
to post-traumatic stress disorder [1,2].
Smoke is a complex mixture of carbon dioxide, water
vapour, carbon monoxide, particulate matter, hydrocar-
bons and other organic chemicals, nitrogen oxides and
trace minerals. Exposure to particulate matter is the
main public health threat from short-term exposure to
wildfire smoke. In particular, fine airborne particles
(PM2.5 or particles having an aerodynamic diameter <
2.5 micrometres) constitute the air pollutant with the
greatest increase in concentrations during fire events.
PM2.5 are able to penetrate deep into the respiratory
tract, and may cause a whole range of health problems
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reproduction in any medium, provided the original work is properly cited.[3,4]. In regulatory guidelines issued by the World
Health Organisation (WHO) [5], all particulate matter
of a given size class is assumed to be equally toxic
regardless of source (biomass as opposed to fossil fuel
combustion) or chemical composition. Yet, a number of
authors disagree with this and consider that, in view of
the currently available evidence in this field, there is a
gap in our knowledge [6,7].
Although the adverse effects of urban fine particulate
air pollution (PM2.5) on respiratory health are well docu-
mented, far fewer studies have evaluated the impact of
wildfire-generated PM2.5, due to the sporadic, unpredict-
able nature of wildfires and the tendency for air pollution
monitors to be situated in predominantly urban areas of
highest population concentration [6,8]. Studies that have
evaluated the impact of wildfire particulate matter on
hospital admissions, emergency department visits or out-
patient visits have reported associations with respiratory
outcomes (asthma in particular, but also acute bronchitis
and chronic obstructive pulmonary disease).
Drug utilisation research was defined by the World
Health Organisation in 1977 as, «the marketing, distribu-
tion, prescription, and use of drugs in a society, with spe-
cial emphasis on the resulting medical, social and
economic consequences» [9]. Drug utilisation research
can be an excellent tool for measuring the morbidity of a
population, e.g., by estimating the prevalence of diabetes
through the consumption of insulin, oral antidiabetics and
other subcutaneously administered antidiabetics [10-12].
Epidemiological assessment of the impact had on dis-
ease by natural disasters requires data from the periods
before and after the event. As developed countries gen-
erally have enough resources for disease surveillance,
pre-disaster information is usually obtainable. Post-dis-
aster information may be limited, however, due to
severe challenges to the health system posed by the dis-
aster, such as mass migration, damaged infrastructure or
saturation of health facilities [13].
Drug utilisation data in Spain are recorded in the bill-
ing database managed by the Pharmaceutical Board on
the basis of all official prescriptions dispensed. The
Spanish pharmaceutical network is made up of many,
small, widely distributed pharmacies (each attending to
approximately 1,500 inhabitants). By law, pharmacists
may only dispense prescription drugs (Rx-only) on pro-
duction of an official prescription signed by a physician.
Where such prescriptions are signed by a National
Health Service physician, the customer pays 40% of the
retail price of the medication, except in the case of pen-
sioners who are entitled to receive medication free of
charge. Once such consumption data have been entered
into the country’s computerised information systems,
they may be accessed and used by health services at any
time (pre- and post-disaster).
Little pharmacoepidemiological research has addressed
changes in prescription profiles in the wake of a disas-
ter. Some studies have been published on increased pre-
scription rates following an earthquake or terrorist
attack [14-16]. There is less information when it comes
to seeking a link between fires and drug utilisation
[17,18] and almost nothing, if one confines oneself
exclusively to forest fires [19].
The main aim of this study was to analyse the respira-
tory and mental health effects of the August-2006 Gali-
cian wildfires, using consumption of anxiolytics-
hypnotics and drugs for obstructive airway diseases
(DOADs) as indicators.
Methods
We conducted an analytical, ecological, geographical-
and temporal-cluster study. The study unit used was
municipality-month (156 municipalities * 27 months, n
= 4212) in the Galician provinces of Corunna (AC o r -
uña) and Pontevedra.
Settings
D u r i n gt h es u m m e ro f2 0 0 6 ,aw a v eo fw i l d f i r e ss t r u c k
Galicia (north-west Spain), giving rise to a disaster situa-
tion in which a great deal of the territory was destroyed
[20,21] (Figure 1). Unlike other occasions, the wildfires
in this case also threatened farms, houses and even
human lives, with the result that the perception of disas-
ter and helplessness was probably the greatest ever
experienced in recent years. By the end of that August,
a total of 83,000 hectares (7.5% of the territory or 11%
of forest surface) in the provinces of Corunna and Pon-
tevedra had been affected by wildfires [22].
In 2006, consumption of benzodiazepine anxiolytics in
Spain stood at 46.51 defined daily doses per 1000 inha-
bitants per day (DDDs), whereas consumption of hypno-
tics was 22.19 DDDs [23]. Consumption of DOADs is
approximately 45 DDDs [24]. Studies show an increase
in consumption of around 63% from 1992 to 2006 [24].
Data-collection
The number of wildfires which had occurred in the
respective municipalities in August 2006 was obtained
from the Ministry of the Environment [22].
To calculate the consumption, in DDDs, of anxioly-
tics-hypnotics (N05C and N05B) and DOADs (R03) for
each municipality-month, the following three databases
were used: 1) the primary health care pharmaceutical
billing database managed by the Pharmaceutical Board.
This database registers all prescriptions issued by pri-
mary care physicians at health facilities managed by the
Galician Health Service, which covers approximately
90% of the population. This study was conceived and
designed on the assumption that medicines prescribed
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same municipality; 2) the Individual Health Card data-
base, which shows the number of inhabitants (popula-
tion) eligible for Galician Health Service pharmaceutical
care, and was used to calculate the indicators; and 3)
the Health Ministry’s Nomenclátor Digitalis, a database
that lists all publicly funded medication and contains
the fields required to calculate the number of defined
daily doses of each drug consumed.
Based on the above information, the wildfires that
occurred in August 2006 were allocated to the pertinent
municipalities, and the respective DDDs of anxiolytics-
hypnotics (N05C and N05B) and DOADs (R03) were
allocated to each municipality-month.
Insofar as anxiolytics and hypnotics are concerned,
other than their pharmacokinetic differences and
strength, it is difficult to find a pharmacodynamic justifi-
cation for this division of benzodiazepines and equiva-
lents into two therapeutic subgroups. To better
understand the higher consumption of benzodiazepines
classified as anxiolytics in our health setting, this should
be explained along with their conditions of use, charac-
terised in most cases by a low or single nightly dose and
short/medium plasma half-life, which is rather similar to
treatment with hypnotics. In view of this, we felt it
would be very difficult to justify a strict classification of
these molecules into the above two groups, and so
decided to carry out a joint analysis for both subgroups
[23].
Variables
The independent variable was number of wildfires which
had occurred in the municipality in August 2006. Muni-
cipalities were thus classified into the following three
categories: no exposure (0 to 3 wildfires); medium expo-
sure (from 4 to 10 wildfires); and high exposure (more
than 10 wildfires).
Two dependent variables were defined, namely: (1)
DDDs of anxiolytics-hypnotics; and (2) DDDs of drugs
for obstructive airway diseases. All variables were calcu-
lated independently for male non-pensioners, female
non-pensioners, male pensioners and female pensioners.
Since measuring the 12 months prior to and after social
perception of a catastrophe enables the results to be
standardised, we calculated these variables for the two
12-month periods pre- and post-August 2006.
Statistical analysis
We first performed an exploratory analysis of the data,
describing the independent (Table 1) and dependent
variables (Table 2) and calculating the averages for the
pre- and post-fire periods (Table 3). To avoid seasonal-
ity, this last calculation was made solely for the months
of August and September.
We then examined the possible effect of forest fires on
the use of anxiolytics-hypnotics and DOADs by means
of additive models for time series [25]. The response
variables were defined as consumption, in DDDs, of
anxiolytics-hypnotics and DOADs, and the explanatory
variables considered were municipal level of exposure,
and the period, prior and subsequent to the fires, as
well as the interaction between the two. To interpret
this interaction more intuitively, i.e., of both the esti-
mated coefficients and the confidence intervals, a new
variable was created that incorporated both crossings
[26]. Each category of this new variable indicated the
trend in drug consumption by exposure level before and
after the fire (Table 4). Moreover, the time trend in the
Figure 1 Wildfires in north-west Spain in August 2006, and satellite photograph.
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enable residual autocorrelations to be avoided and the
events deemed independent. Thin-plate regression
splines were used as trend smoothers, as proposed by
Wood [27], and the optimal degrees of freedom were
automatically selected using a generalised cross-valida-
tion criterion [28]. The analysis was performed for four
population groups, due to the fact that consumption, of
both anxiolytics-hypnotics and DOADs, is very different
for each. The distribution of the consumption of the
total population was multimodal and asymmetric. While
aggregating data by gender yields a bimodal distribution
(two populations), grouping data by occupation yields
an asymmetric distribution. When considering four
population groups, however, distribution of consump-
tion is Gaussian for each.
For estimating the models, we used the gam function,
implemented in the context of the mgcv R package (ver-
sion 2.10.1) [29].
Results
Figure 1 depicts wildfire distribution in north-west
S p a i ni nA u g u s t2 0 0 6 .T h em a i nc h a r a c t e r i s t i c so ft h e
municipalities are broken down by level of exposure in
Table 1, and consumption of anxiolytics-hypnotics and
DOADs is listed in Table 2. Table 3 shows the post-
fire increase in consumption of each group of medi-
cines, with the respective percentage increases accord-
ing to subject aggregation and municipal exposure
level.
The results revealed a higher consumption of DOADs
among pensioners during the months after the wildfires,
in municipalities affected versus those unaffected by fire
(Table 4). The regression coefficients showed that, in
municipalities with high exposure after fires, male pen-
sioners’ consumption increased by 17.69 DDDs (95% CI:
0.86-34.51) (Table 4). Drawing on the average consump-
tion of the control group for these subjects, 171.89 DDDs,
this increase represented a relative increase in consump-
tion of 10.29% (p <0.05). Finally, among female pensioners,
the relative increase was 12.09% (p <0.05) (average
increase of 11.84 DDDs (95% CI: 6.19-23.49) (Table 4);
baseline control group, 97.90 DDDs). There were no sig-
nificant changes with respect to non-pensioners (Table 4).
Insofar as consumption of anxiolytics-hypnotics was
concerned, there was a significant increase among men
overall -pensioners and non-pensioners- in fire-affected
municipalities (Table 4). Thus, while male non-pen-
sioners registered a relative increase of 12.2% (p <0.05)
(average increase of 2.54 DDDs (95% CI: 0.68-4.41)
(Table 4); baseline control group, 20.87 DDDs), male
pensioners registered a relative increase of 15.88% (p
<0.05) (average increase of 21.47 DDDs (95% CI: 9.74-
33.21) (Table 4); baseline control group 135.19 DDDs).
No effect was observed for women, however.
Figure 2 depicts the monthly trend in consumption for
aggregations that displayed significant changes after the
wildfires. There is a slight increasing trend especially in
the consumption of DOADs among pensioners during
the months after wildfires.
Table 1 Distribution of municipalities by exposure: number of municipalities, number of wildfires, mean, and
inhabitants covered
Number of municipalities Number of wildfires Mean (95% CI) Inhabitants
No exposure (0 to 3 wildfires) 47 52 1.11 (0.78 - 1.44) 272,549
Medium exposure (4 to 10 wildfires) 54 362 6.70 (6.12 - 7.29) 964,429
High exposure (11 to 58 wildfires) 55 1076 19.56 (17.09 - 22.04) 799,744
Table 2 Consumption of anxiolytics-hypnotics and drugs for obstructive airway diseases
Anxiolytics - Hypnotics (N05B & N05C) Mean (95% CI)
*
Drugs for obstructive airway diseases (R03) Mean (95% CI)
*
Total population 100.55 (99.27 - 101.84) 77.27 (76.21 - 78.32)
Men 83.78 (74.09 - 93.48) 92.76 (81.51 - 104.01)
Women 128.77 (115.90 - 141.64) 56.25 (50.60 - 61.89)
Non-pensioners 35.95 (33.87 - 38.04) 21.90 (21.38 - 22.42)
Pensioners 176.60 (170.95 - 182.25) 127.11 (121.14 - 133.08)
Male non-pensioners 23.21 (22.69 - 23.74) 22.46 (21.74 -23.17)
Female non-
pensioners
48.70 (47.84 - 49.55) 21.34 (20.58 - 22.11)
Male pensioners 144.36 (141.80 - 146.91) 163.07 (160.20 - 165.93)
Female pensioners 208.84 (204.73 - 212.96) 91.15 (89.03 - 93.27)
* Defined daily doses per 1000 inhabitants/day
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Our study indicates that wildfires have a significant
effect on population health, in that they are associated
with a greater consumption of anxiolytics and hypnotics
among men overall, regardless of pensioner status, and
with a greater consumption of DOADs among all pen-
sioners, both male and female.
Current evidence strongly suggests that the victims of
fire disasters are at increased risk of adverse psychological
effects, including post-traumatic stress disorder and
depression [30]. Some researchers have indicated that 24%
of fire victims display symptoms that would lead to a diag-
nosis of post-traumatic stress disorder, and 33% show evi-
dence of probable major depression three months after
Table 3 Consumption of anxiolytics-hypnotics and drugs for obstructive airway diseases: consumption pre-wildfire
(Aug-Sep 2005) and consumption post-wildfire (Aug-Sep 2006)
Anxiolytics - Hypnotics
(N05B & N05C)
Drugs for obstructive airway diseases
(R03)
DDDs* mean and (standard deviation) DDDs* mean and (standard deviation)
Pre-wildfire
period 2005
(Aug - Sep)
Post-wildfire
period 2006
(Aug - Sep)
Pre-wildfire
period 2005
(Aug - Sep)
Post-wildfire
period 2006
(Aug - Sep)
Total population
Municipalities: no exposure 104.26 (89.10) 107.78 (92.40) 75.93 (71.18) 75.62 (71.55)
Municipalities: med. exposure 90.16 (78.14) 100.71 (81.81) 69.51 (67.87) 73.62 (67.21)
Municipalities: high exposure 89.81 (75.82) 99.37 (79.93) 73.26 (69.12) 73.91 (67.46)
Men
Municipalities: no exposure 77.19 (67.84) 79.62 (70.87) 95.46 (86.73) 94.38 (87.09)
Municipalities: med. exposure 68.52 (58.71) 76.86 (62.38) 89.93 (82.84) 92.68 (80.58)
Municipalities: high exposure 67.74 (57.14) 74.81 (61.16) 94.80 (84.15) 94.24 (81.38)
Women
Municipalities: no exposure 131.32 (99.22) 135.95 (102.48) 56.28 (43.02) 56.76 (44.22)
Municipalities: med. exposure 111.70 (88.56) 124.55 (91.57) 49.18 (39.35) 54.48 (42.65)
Municipalities: high exposure 111.89 (85.32) 123.93 (88.62) 51.82 (39.75) 53.58 (40.86)
Non-pensioners
Municipalities: no exposure 35.34 (25.26) 35.37 (23.29) 19.16 (10.01) 18.61 (9.84)
Municipalities: med. exposure 29.17 (17.23) 33.51 (18.39) 16.21 (7.92) 17.01 (7.47)
Municipalities: high exposure 25.95 (17.19) 33.07 (17.56) 17.86 (8.06) 17.18 (6.21)
Pensioners
Municipalities: no exposure 173.17 (75.61) 180.19 (77.69) 131.78 (60.47) 132.33 (60.49)
Municipalities: med. exposure 150.86 (67.03) 167.90 (63.30) 122.56 (58.99) 129.98 (50.84)
Municipalities: high exposure 149.68 (63.47) 165.67 (60.55) 128.41 (58.00) 130.64 (51.16)
Male non-pensioners
Municipalities: no exposure 20.17 (9.75) 19.95 (9.13) 18.81 (9.18) 18.31 (7.48)
Municipalities: med. exposure 18.22 (8.39) 21.17 (8.37) 17.29 (8.08) 17.97 (7.59)
Municipalities: high exposure 18.16 (6.86) 19.93 (7.12) 18.63 (8.17) 17.93 (6.38)
Female non-pensioners
Municipalities: no exposure 50.52 (27.45) 50.81 (22.93) 19.52 (10.82) 18.91 (11.79)
Municipalities: med. exposure 40.02 (16.88) 45.85 (17.37) 15.13 (7.68) 16.04 (7.24)
Municipalities: high exposure 41.74 (16.31) 46.21 (14.85) 17.10 (7.91) 16.42 (5.97)
Male pensioners
Municipalities: no exposure 134.21 (50.85) 139.29 (53.08) 171.30 (57.21) 170.45 (59.13)
Municipalities: med. exposure 118.35 (42.27) 132.55 (38.55) 161.90 (56.20) 167.38 (41.52)
Municipalities: high exposure 117.31 (39.40) 129.69 (37.23) 170.28 (50.44) 170.55 (38.90)
Female pensioners
Municipalities: no exposure 212.12 (76.43) 221.08 (77.07) 92.26 (30.37) 94.21 (30.40)
Municipalities: med. exposure 183.38 (71.47) 203.26 (63.58) 83.23 (26.68) 92.57 (25.39)
Municipalities: high exposure 182.04 (66.53) 201.65 (58.03) 86.55 (26.03) 90.74 (23.06)
* Defined daily doses per 1000 inhabitants/day
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quality and content of the ensuing information, e.g., in one
study that investigated the relationship between exposure
to a forest fire and mental illness, the authors failed to find
an association: this result, which is in contradiction with
the literature [31], may be due to the fact that the effect
was estimated using physician-visit billing data, which may
give rise to possible underestimation due to disease coding
errors and other limitations of this variable.
At the outset, neither acute stress disorder nor post-
traumatic stress disorder should be treated with
medication on a routine basis, without previous evalua-
tion of the subject, and specifically of his/her clinical
severity index and the psychological coping strategies
involved. Should it be necessary to begin pharmacologi-
cal treatment for acute stress disorder, the medicines of
choice are serotonergic antidepressants. In the short
term, however, benzodiazepines may be prescribed to
treat anxiety and insomnia, not only in post-traumatic
but also in acute stress disorder [32,33].
Accordingly, there is a strong likelihood that many of
the people exposed to the Galician forest fires developed
Table 4 Association between wildfires and consumption of anxiolytics- hypnotics and drugs for obstructive airway
diseases: coefficients and p-values of additive models for time series
Anxiolytics - Hypnotics
(N05B & N05C)
Drugs for obstructive airway diseases
(R03)
Male non-
pensioners
Female non-
pensioners
Male
pensioners
Female
pensioners
Male non-
pensioners
Female non-
pensioners
Male
pensioners
Female
pensioners
No exposure pre-wildfires
(Reference category)
0 0 00 0 0 00
Medium exposure pre-
wildfires
3.15
(<0.01)
-0.43
(0.76)
12.22
(<0.01)
-25.70
(<0.01)
-0.11
(0.88)
-1.14
(0.18)
-12.63
(<0.01)
-8.88
(<0.01)
High exposure pre-wildfires 1.39
(0.05)
0.58
(0.68)
0.82
(0.82)
0.45
(0.93)
-0.34
(0.66)
-1.23
(0.15)
3.76
(0.34)
2.34
(0.36)
No exposure post-wildfires -1.08
(0.26)
-0.30
(0.87)
3.96
(0.51)
1.42
(0.87)
0.42
(0.83)
-0.29
(0.89)
12.55
(0.15)
9.44
(0.12)
Medium exposure post-
wildfires
2.54
(0.01)
-0.36
(0.85)
21.47
(<0.01)
-17.20
(0.05)
1.13
(0.56)
-0.57
(0.79)
-0.56
(0.95)
0.91
(0.88)
High exposure post-wildfires 0.81
(0.40)
1.77
(0.35)
10.42
(0.09)
9.13
(0.29)
-0.25
(0.90)
-1.44
(0.49)
17.69
(0.04)
11.84
(0.04)
Figure 2 Consumption of anxiolytics-hypnotics (N05B & NO5C) and drugs for obstructive airway diseases (R03): trends pre- and post-
wildfires.
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were initially treated with benzodiazepines. The greater
baseline consumption in women might account for the
fact that no increase was found in municipalities
affected by forest fires (Table 4), given that it is more
difficult to find significant increases in cases where base-
line consumption is high (Table 2). In men, on the other
hand, among non-pensioners and pensioners alike
(Table 4), the increase in hypnotics and anxiolytics
proved to be significant, and this seems to be coherent
with the fact that their baseline consumption was much
lower than that of women (Table 2). Our finding of
higher baseline consumption of anxiolytics and hypno-
tics among women versus men (Table 2) coincides with
data reported by other researchers [34]. The 2006
National Health Survey (Encuesta Nacional de Salud
2006) [35] reveals that the percentage of persons that
had consumed, “tranquilisers, relaxants and sleeping
pills”, i.e., benzodiazepines, within the preceding two
weeks was considerable, and higher in women than in
men (17.5% versus 10.18% respectively). This higher pre-
valence of consumption among women may be due to a
higher degree of psychiatric morbidity [33-37], a lower
tolerance to stress [38], a tendency to seek help for psy-
chiatric problems more often [36], a higher degree of
acceptance of treatment [37] and a higher probability of
being frequent attenders in general practice [35,39,40]
than their male counterparts, all of which is linked to
greater consumption of psychopharmaceutical drugs
[33].
In our study, DOAD consumption increased signifi-
cantly among pensioners (men and women) (Table 4).
This result is coherent with the fact that a recent stress-
ful event, and emotional stress in general, constitutes a
risk factor for poor asthma control [41]. It is also line
with the conclusions reached in the most significant
study published to date regarding the impact of a large-
scale forest fire on cardio-respiratory morbidity, namely,
that the strongest association between exposure to parti-
cles smaller than 2.5 micra and hospital admissions due
to asthma is to be found in the population aged 65-99
years (an increase of 10.1%) [8]. In this respect, it should
be noted that 77% of all pensioners in Spain are over
the age of 65 years [42,43].
Our study has the following three main limitations: (1)
it has been argued that the validity of these types of stu-
dies can be questioned [10,44], due to underdiagnosis
[10], drug non-specificity for a single pathology
[9,10,44], existence of patients diagnosed for non-phar-
macological treatments [10], physician-prescribed medi-
cation that is not dispensed to patients in pharmacies
(non-fulfilment) [45,46] and use of prescribed medica-
tion under conditions other than those established in
the drug prospectus inserted in the package.
Nevertheless, these limitations vary according to the
source of the data and may not be significant when the
trend in consumption is analysed and a control group is
available; (2) measurement of the dependent variable
assumes that all medication sold in pharmacies within a
given ecological unit are consumed by the population
from that same unit, an assumption that may not neces-
sarily be correct. In contrast, a cohort study would
enable a specific consumption of medicines to be allo-
cated to each subject (optimum design). Even so, we
consider that our assumption may prove to be a good
approximation, bearing in mind that there is a very uni-
form, widespread network of pharmacies in Galicia. In
this particular case, therefore, the validity of a cohort
study would be similar to that of an ecological study;
and, (3) the primary healthcare database does not
include prescriptions issued by hospitals, civil servant
mutual insurance companies and private doctors. How-
ever, this limitation would mainly affect the study’s
descriptive results: its analytical results would be
affected to a lesser extent, and primary healthcare pre-
scriptions for hypnotics and anxiolytics have been esti-
mated to represent around 87% of the total [47], most
of which is dispensed by medical prescription [48].
Conclusions
Our study indicates that wildfires have a significant
effect on population health. The coherence of these
results suggests that drug utilisation research is a useful
tool for studying morbidity associated with environmen-
tal incidents.
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